Circulation, Vol 52, 823-827, Copyright © 1975 by American Heart Association
RE Kerber and B Sherman
Pericardial effusion is a recognized consequences of myxedema. Its
incidence is unknown, primarily because of past difficulties in
establishing the diagnosis. We studied 33 hypothyroid patients by
echocardiography. Ten of the 33 patients (30%) had positive echoes for
pericardial effusion. Seven of these ten patients had enlarged hearts on
chest X-ray. Five patients had cardiac enlargement but no echo evidence of
pericardial effusion. Serum concentrations of thyroxine, 1.8+/-0.3 vs
1.5+/-0.1 mcg/dl and of thyroid stimulating hormone, 34+/- 4 vs 38+/-5
muU/ml did not differ in the groups with and without pericardial effusion,
respectively. However, the pericardial effusion group had significantly
slower heart rates on ECG than those without pericardial effusion: 53+/-8
vs 68+/-2 beats/min, P less than 0.05. Low voltage was present in five of
the ten patients with pericardial effusion and five of the 23
nonpericardial effusion patients. None of the patients with pericardial
effusion developed tamponade. Seven patients with pericardial effusion were
restudied after periods of thyroxine replacement therapy ranging from six
months to two years. All were euthyroid and had negative echoes on
follow-up, but two still showed cardiomegaly on chest X-ray (both had
associated coronary artery disease). We conclude that pericardial effusion
occurs frequently in patients with myxedema. Tamponade is uncommon and the
effusions disappear with thyroid replacement therapy. Cardiomegaly on chest
X-ray and low voltage on ECG are not reliable indicators of pericardial
effusion.
ARTICLES
Echocardiographic evaluation of pericardial effusion in myxedema. Incidence and biochemical and clinical correlations
This article has been cited by other articles:
![]() |
Task Force members, B. Maisch, P. M. Seferovic, A. D. Ristic, R. Erbel, R. Rienmuller, Y. Adler, W. Z. Tomkowski, G. Thiene, M. H. Yacoub, et al. Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology Eur. Heart J., April 1, 2004; 25(7): 587 - 610. [Full Text] [PDF] |
||||
![]() |
C. Usalan, E. Atalar, and F. K. Vural Pericardial tamponade in a 65-year-old woman Postgrad. Med. J., March 1, 1999; 75(881): 183 - 185. [Full Text] |
||||
![]() |
A. S. Manolis, P. Varriale, and R. M. Ostrowski Hypothyroid Cardiac Tamponade Arch Intern Med, June 1, 1987; 147(6): 1167 - 1169. [Abstract] [PDF] |
||||
![]() |
S. Arvan Pericardial Tamponade in a Patient With Treated Myxedema Arch Intern Med, October 1, 1983; 143(10): 1983 - 1984. [Abstract] [PDF] |
||||
![]() |
Z. Q. Farooki, W. H. Hoffman, B. L. Perry, and E. W. Green Myocardial Dysfunction in Hypothyroid Children Arch Pediatr Adolesc Med, January 1, 1983; 137(1): 65 - 68. [Abstract] [PDF] |
||||
![]() |
J. T. Hayford, R. M. Schieken, and R. G. Thompson Cardiac Function in Primary Hypothyroidism Arch Pediatr Adolesc Med, June 1, 1980; 134(6): 556 - 559. [Abstract] [PDF] |
||||
![]() |
A. L. Riba and J. Morganroth Unsuspected Substantial Pericardial Effusions Detected by Echocardiography JAMA, December 6, 1976; 236(23): 2623 - 2625. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1975 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |